Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy

被引:87
作者
Yarasheski, KE
Tebas, P
Stanerson, E
Claxton, S
Marin, D
Bae, K
Kennedy, M
Tantisiriwat, W
Powderly, WG
机构
[1] Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Radiol Sci, St Louis, MO 63110 USA
关键词
AIDS; metabolic complications; progressive resistance exercise training; muscle protein mass; lipid metabolism; magnetic resonance imaging;
D O I
10.1152/jappl.2001.90.1.133
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hypertriglyceridemia, peripheral insulin resistance, and trunk adiposity are metabolic complications recently recognized in people infected with human immunodeficiency virus (HIV) and treated with highly active antiretroviral therapy (HAART). These complications may respond favorably to exercise training. Using a paired design, we determined whether 16 wk of weight-lifting exercise increased muscle mass and strength and decreased fasting serum triglycerides and adipose tissue mass in 18 HIV-infected men. The resistance exercise regimen consisted of three upper and four lower body exercises done for 1-1.5 h/day, 4 days/wk for 64 sessions. Dual-energy X-ray absorptiometry indicated that exercise training increased whole body lean mass 1.4 kg (P = 0.005) but did not reduce adipose tissue mass (P = NS). Axial proton-magnetic resonance imaging indicated that thigh muscle cross-sectional area increased 5-7 cm(2) (P < 0.005). Muscle strength increased 23-38% (P < 0.0001) on all exercises. Fasting serum triglycerides were decreased at the end of training (281-204 mg/dl; P = 0.02). These findings imply that resistance exercise training-induced muscle hypertrophy may promote triglyceride clearance from the circulation of hypertriglyceridemic HIV-infected men treated with antiviral therapy.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 28 条
[21]   Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss - A randomized controlled trial [J].
Strawford, A ;
Barbieri, T ;
Van Loan, M ;
Parks, E ;
Catlin, D ;
Barton, N ;
Neese, R ;
Christiansen, M ;
King, J ;
Hellerstein, MK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (14) :1282-1290
[22]   The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients [J].
Stringer, WW ;
Berezovskaya, M ;
O'Brien, WA ;
Beck, CK ;
Casaburi, R .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1998, 30 (01) :11-16
[23]   Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy [J].
Tebas, P ;
Powderly, WG ;
Claxton, S ;
Marin, D ;
Tantisiriwat, W ;
Teitelbaum, SL ;
Yarasheski, KE .
AIDS, 2000, 14 (04) :F63-F67
[24]   INCREASED HDL-CHOLESTEROL LEVELS WITH A WEIGHT LIFTING PROGRAM [J].
ULLRICH, IH ;
REID, CM ;
YEATER, RA .
SOUTHERN MEDICAL JOURNAL, 1987, 80 (03) :328-331
[25]   Effects of cross training on markers of insulin resistance hyperinsulinemia [J].
Wallace, MB ;
Mills, BD ;
Browning, CL .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1997, 29 (09) :1170-1175
[26]  
WARNICK GR, 1982, CLIN CHEM, V28, P1379
[27]   Insulin resistance in HIV protease inhibitor-associated diabetes [J].
Yarasheski, KE ;
Tebas, P ;
Sigmund, C ;
Dagogo-Jack, S ;
Bohrer, A ;
Turk, J ;
Halban, PA ;
Cryer, PE ;
Powderly, WG .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03) :209-216
[28]  
YARASHESKI KE, 1992, AM J PHYSIOL, V262, P261